Evidence map›Paper›PMID 38254670›Full record

ArticleBiomolecules2024

SOX2 and SOX9 Expression in Developing Postnatal Opossum (

Zrinko Baričević, Marta Pongrac, Matea Ivaničić, Helena Hreščak, Ivana Tomljanović, Antonela Petrović, Dan Cojoc, Miranda Mladinic, Jelena Ban

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Zrinko BaričevićFaculty of Biotechnology and Drug Development, University of Rijeka, Radmile Matejčić 2, 51000 Rijeka, Croatia.ORCID 0000-0002-7719-6772
Marta PongracFaculty of Biotechnology and Drug Development, University of Rijeka, Radmile Matejčić 2, 51000 Rijeka, Croatia.
Matea IvaničićFaculty of Biotechnology and Drug Development, University of Rijeka, Radmile Matejčić 2, 51000 Rijeka, Croatia.ORCID 0000-0001-6661-736X
Helena HreščakFaculty of Biotechnology and Drug Development, University of Rijeka, Radmile Matejčić 2, 51000 Rijeka, Croatia.
Ivana TomljanovićFaculty of Biotechnology and Drug Development, University of Rijeka, Radmile Matejčić 2, 51000 Rijeka, Croatia.
Antonela PetrovićFaculty of Biotechnology and Drug Development, University of Rijeka, Radmile Matejčić 2, 51000 Rijeka, Croatia.
Dan CojocCNR-IOM, Materials Foundry, National Research Council of Italy, 34149 Trieste, Italy.ORCID 0000-0003-2243-4478
Miranda MladinicFaculty of Biotechnology and Drug Development, University of Rijeka, Radmile Matejčić 2, 51000 Rijeka, Croatia.ORCID 0000-0002-3985-6629
Jelena BanFaculty of Biotechnology and Drug Development, University of Rijeka, Radmile Matejčić 2, 51000 Rijeka, Croatia.ORCID 0000-0001-5792-3998
University of Rijeka · HRNational Research Council · IT

Funding

Croatian Science Foundation IP-2016-06-7060University of Rijeka uniri-biomed-18-258- 6427University of Rijeka uniri-prirod-18-290-1463
6 · The paper itself

Abstract

(1) Background: Central nervous system (CNS) development is characterized by dynamic changes in cell proliferation and differentiation. Key regulators of these transitions are the transcription factors such as SOX2 and SOX9. SOX2 is involved in the maintenance of progenitor cell state and neural stem cell multipotency, while SOX9, expressed in neurogenic niches, plays an important role in neuron/glia switch with predominant expression in astrocytes in the adult brain. (2) Methods: To validate SOX2 and SOX9 expression patterns in developing opossum (

Indexed as

MonodelphisNeural Stem CellsSOX Transcription FactorsAnimalsCerebral CortexNeurogliaNeuronsSOX Transcription Factorscortexdevelopmentisotropic fractionatorneurogenesisopossumprimary neuronal culturesSOX2SOX9

Identifiers

PMID38254670
PMCPMC10813269
OpenAlexW4390615960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.